[1]
|
Walker, E.D. and Stachecki, J.A. (2008) Livestock Pest Management. A Training Manual for Commercial Pesticide Applicators. New York.
|
[2]
|
Strle, F., Nadelman, R.B., Cimperman, J., et al. (1999) Comparison of Culture-Confirmed Erythema Migrans Caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Annals of Internal Medicine, 130, 32-36.
http://dx.doi.org/10.7326/0003-4819-130-1-199901050-00006
|
[3]
|
Nadelman, R.B., Nowakowski, J., Forseter, G., et al. (1996) The Clinical Spectrum of Early Lyme Borreliosis in Patients with Culture-Confirmed Erythema Migrans. The American Journal of Medicine, 100, 502-508. http://dx.doi.org/10.1016/S0002-9343(95)99915-9
|
[4]
|
Piesman, J., Mather, T.N., Sinsky, R.J. and Spielman, A. (1987) Duration of Tick Attachment and Borrelia burgdorferi Transmission. Journal of Clinical Microbiology, 25, 557-558.
|
[5]
|
Bacon, R.M., Kugeler, K.J. and Mead, P.S. (2008) Surveillance for Lyme Disease—United States, 1992-2006. MMWR Surveill Summ, 57, 1-9.
|
[6]
|
Walker, E.D. and Stachecki, J.A. (2008) Livestock Pest Management. A Training Manual for Commercial Pesticide Applicators, 54.
|
[7]
|
Stafford, K.C. (2004) Tick Management Handbook. The Connecticut Agricultural Experiment Station, Connecticut General Assembly, New Haven.
|
[8]
|
Daniels, T.J., Boccia, T.M., Varde, S., Marcus, J., Le, J., Bucher, D.J., Falco, R.C. and Schwartz, I. (1998) Geographic Risk of Lyme Disease and Human Granulocytic Ehrlichiosis in Southern New York State. Applied and Environmental Microbiology, 64, 4663-4669.
http://aem.asm.org/cgi/content/full/64/12/4663?view=long&pmid=9835546
|
[9]
|
Hanrahan, J.P., Benach, J.L., Coleman, J.L., Bosler, E.M., Grabau, J.C. and Morse, D.L. (1984) Epidemiologic Features of Lyme Disease in New York. Yale Journal of Biology and Medicine, 57, 643-650.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590009/pdf/yjbm00100-0190.pdf
|
[10]
|
Joseph, J. and Burrascano Jr., M.D. (2008) Advanced Topics in Lyme Disease, Diagnostic Hints and Treatment Guidelines for Lyme and Other Tick Borne Illnesses. 6th Edition, International Lyme and Associated Diseases Society.
|
[11]
|
Marques, A.R. (2010) Lyme Disease: A Review. Current Allergy and Asthma Reports, 10, 13-20.
|
[12]
|
Wormser, G.P. (2006) The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America, by the Infectious Diseases Society of America.
|
[13]
|
Dattwyler, R.J., Halperin, J.J., Volkman, D.J. and Luft, B.J. (1988) Treatment of Late Lyme Borreliosis—Randomized Comparison of Ceftriaxone and Penicillin. Lancet, 331, 1191- 1194. http://dx.doi.org/10.1016/S0140-6736(88)92011-9
|
[14]
|
Wormser, G.P., Liveris, D., Hanincova, K., et al. (2008) Effect of Borrelia burgdorferi Genotype on the Sensitivity of C6 and 2-Tier Testing in North American Patients with Culture-Confirmed Lyme Disease. Clinical Infectious Diseases, 47, 910-914.
http://dx.doi.org/10.1086/591529
|
[15]
|
Strle, F., Ruzic-Sabljic, E., Cimperman, J., et al. (2006) Comparison of Findings for Patients with Borreliagarinii and Borreliaafzelii Isolated from Cerebrospinal Fluid. Clinical Infectious Diseases, 43, 704-710. http://dx.doi.org/10.1086/506936
|
[16]
|
Wormser, G.P., Brisson, D., Liveris, D., et al. (2008) Borrelia burgdorferi Genotype Predicts the Capacity for Hematogenous Dissemination during Early Lyme Disease. The Journal of Infectious Diseases, 198, 1358-1364. http://dx.doi.org/10.1086/592279
|
[17]
|
Oraze, M.J. and Charland, S.J. (1995) Lyme Disease Surveillance and Prevention Plan. Naval Surface Warfare Center, Naval Sea Systems Command, United States Navy, Indian Head, MD.
|
[18]
|
Wormser, G.P., Dattwyler, R.J., Shapiro, E.D., Halperin, J.J., Steere, A.C., Klempner, M.S., Krause, P.J., Bakken, J.S., Strle, F., Stanek, G., Bockenstedt, L., Fish, D., Dumler, J.S. and Nadelman, R.B. (2006) The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Disease Society of America. Clinical Infectious Diseases, 43, 1089-1134.
http://cid.oxfordjournals.org/content/43/9/1089.long
http://dx.doi.org/10.1086/508667
|
[19]
|
Philipp, M.T., Marques, A.R., Fawcett, P.T., Dally, L.G. and Martin, D.S. (2003) C6 Test as an Indicator of Therapy Outcome for Patients with Localized or Disseminated Lyme Borreliosis. Journal of Clinical Microbiology, 41, 4955-4960.
http://dx.doi.org/10.1128/JCM.41.11.4955-4960.2003
|
[20]
|
Vermeersch, P., Resseler, S., Nackers, E. and Lagrou, K. (2009) The C6 Lyme Antibody Test Has Low Sensitivity for Antibody Detection in Cerebrospinal Fluid. Diagnostic Microbiology & Infectious Disease, 64, 347-349. http://dx.doi.org/10.1016/j.diagmicrobio.2009.03.013
|
[21]
|
Brorson, O. and Brorson, S.H. (1998) In Vitro Conversion of Borrelia burgdorferi to Cystic Forms in Spinal Fluid, and Transformation to Mobile Spirochetes by Incubation in BSK-H Medium. Infection, 26, 144-150. http://dx.doi.org/10.1007/BF02771839
|
[22]
|
Alban, P.S., Johnson, P.W. and Nelson, D.R. (2000) Serum-Starvation-Induced Changes in Protein Synthesis and Morphology of Borrelia burgdorferi. Microbiology, 146, 119-127.
http://dx.doi.org/10.1099/00221287-146-1-119
|
[23]
|
Fact Sheet (2006) Lyme Disease. Department of Health and Human Services, Division of Public Health Services.
|
[24]
|
Klempner, M.S. (2002) Controlled Trials of Antibiotic Treatment in Patients with Post- Treatment Chronic Lyme Disease. Vector-Borne and Zoonotic Diseases, 2, 255-263.
http://dx.doi.org/10.1089/153036602321653842
|
[25]
|
Klempner, M.S., Hu, L., Evans, J., Schmid, C.H., Johnson, G.M., Trevino, R.P., Norton, D., Levy, L., Wall, D., McCall, J., Kosinski, M. and Weinstein, A. (2001) Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease. The New England Journal of Medicine, 345, 85-92.
http://dx.doi.org/10.1056/NEJM200107123450202
|
[26]
|
Fallon, B.A., Keilp, J.G., Corbera, K.M., Petkova, E., Britton, C.B., Dwyer, E., Slavov, I., Cheng, J., Dobkin, J., Nelson, D.R. and Sackeim, H.A. (2008) A Randomized, Placebo-Con- trolled Trial of Repeated IV Antibiotic Therapy for Lyme Encephalopathy. Neurology, 70, 992-1003. http://dx.doi.org/10.1212/01.WNL.0000284604.61160.2d
|
[27]
|
Steere, A.C., Dhar, A., Hernandez, J., et al. (2003) Systemic Symptoms without Erythema Migrans as the Presenting Picture of Early Lyme Disease. The American Journal of Medicine, 114, 58-62. http://dx.doi.org/10.1016/S0002-9343(02)01440-7
|
[28]
|
Bakken, J.S. and Dumler, S. (2008) Human Granulocytic Anaplasmosis. Infectious Disease Clinics of North America, 22, 433-448. http://dx.doi.org/10.1016/j.idc.2008.03.011
|
[29]
|
Logigian, E.L., Kaplan, R.F. and Steere, A.C. (1990) Chronic Neurologic Manifestations of Lyme Disease. The New England Journal of Medicine, 323, 1438-1444.
http://dx.doi.org/10.1056/NEJM199011223232102
|
[30]
|
Fallon, B.A. and Nields, J.A. (1994) Lyme Disease: A Neuropsychiatric Illness. The American Journal of Psychiatry, 151, 1571-1583. http://dx.doi.org/10.1176/ajp.151.11.1571
|
[31]
|
Asch, E.S., Bujak, D.I., Weiss, M., Peterson, M.G.E. and Weinstein, A. (1994) Lyme Disease: An Infectious and Postinfectious Syndrome. The Journal of Rheumatology, 21, 454-456.
|
[32]
|
Stricker, R.B. and Lautin, A. (2003) The Lyme Wars: Time to Listen. Expert Opinion on Investigational Drugs, 12, 1609-1614. http://dx.doi.org/10.1517/13543784.12.10.1609
|
[33]
|
Nadelman, R.B. and Wormser, G.P. (1995) Erythema Migrans and Early Lyme Disease. The American Journal of Medicine, 98, S15-S24.
http://dx.doi.org/10.1016/S0002-9343(99)80040-0
|
[34]
|
Nowakowski, J., McKenna, D., Nadelman, R.B., et al. (2000) Failure of Treatment with Cephalexin for Lyme Disease. Archives of Family Medicine, 9, 563-567.
http://dx.doi.org/10.1001/archfami.9.6.563
|
[35]
|
Burrascano Jr., J.J. (2008) Diagnostic Hints and Treatment Guidelines for Lyme and Other Tick Borne Diseases.
|
[36]
|
Eppes, S.C., Klein, J.D., Caputo, G. and Rose, C.D. (1994) Physician Beliefs, Attitudes and Approaches toward Lyme Disease in an Endemic Area. Clinical Pediatrics, 33, 130-134.
http://dx.doi.org/10.1177/000992289403300301
|
[37]
|
Peña, C.A., Mathews, A.A., Siddiqi, N.H. and Strickland, G.T. (1999) Antibiotic Therapy for Lyme Disease in a Population-Based Cohort. Clinical Infectious Diseases, 29, 694-695.
http://dx.doi.org/10.1086/598665
|
[38]
|
Fallon, B.A. (2000) Chronic Lyme Disease Research Study. A Double-Blind Placebo-Controlled Randomized Clinical Trial Evaluating the Efficacy of Ten Weeks of iv. Ceftriaxone and Effects on Brain Imaging. Enrollment Since 2000.
|
[39]
|
Feder Jr., H.M. (2000) Differences Are Voiced by Two Lyme Camps at a Connecticut Public Hearing on Insurance Coverage of Lyme Disease. Pediatrics, 105, 855-857.
http://dx.doi.org/10.1542/peds.105.4.855
|
[40]
|
Fallon, B.A., Tager, F., Keilp, J., Weiss, N., Liebowitz, M.R., Fein, L. and Liegner, K. (1999) Repeated Antibiotic Treatment in Chronic Lyme Disease. J. Spiro Tick Dis, 6, 94-102.
|
[41]
|
Battaglia, H.R., Alvarez, G., Mercau, A., Fay, M. and Campodónico, M. (2000) Psychiatric Symptomatology Associated with Presumptive Lyme Disease: Clinical Evidence. J. Spirol. Tick Dis, 7, 22-25.
|
[42]
|
Ziska, M.H., Donta, S.T. and Demarest, F.C. (1996) Physician Preferences in the Diagnosis and Treatment of Lyme Disease in the United States. Infection, 24, 182-186.
http://dx.doi.org/10.1007/BF01713336
|
[43]
|
Cameron, D.J. (2001) Lyme Disease Retreatment Study. A Double-Blind Placebo-Controlled Randomized Clinical Trial Evaluating the Efficacy of Oral Amoxicillin for Seropositive and Seronegative Lyme Disease. Enrollment Since 2001.
|
[44]
|
Cerar, T., Rusic-Sabljic, E., Glinsek, U., Zore, A. and Strle, F. (2008) Comparison of PCR Methods and Culture for the Detection of Borrelia spp. in Patients with Erythema Migrans. Clinical Microbiology and Infection, 14, 653-658.
http://dx.doi.org/10.1111/j.1469-0691.2008.02013.x
|
[45]
|
Lebech, A.M., Hansen, K., Brandrup, F., et al. (2000) Diagnostic Value of PCR for Detection of Borrelia burgdorferi DNA in Clinical Specimens from Patients with Erythema Migrans and Lyme Neuroborreliosis. Molecular Diagnosis, 5, 139-150.
|
[46]
|
Wahlberg, P., Granlund, H., Nyman, D., Panelius, J. and Seppala, I. (1994) Treatment of Late Lyme Borreliosis. Journal of Infection, 29, 255-261.
http://dx.doi.org/10.1016/S0163-4453(94)91105-3
|
[47]
|
Donta, S.T. (1997) Tetracycline Therapy for Chronic Lyme Disease. Clinical Infectious Diseases, 25, S52-S56. http://dx.doi.org/10.1086/516171
|
[48]
|
Bean, C.A. and Fein, L.A. (2008) Beating Lyme, Understanding and Treating This Complex and Often Misdiagnosed Disease. AMACOM, New York.
|
[49]
|
Vannier, E., Gewurz, B.E. and Krause, P.J. (2008) Human Babesiosis. Infectious Disease Clinics of North America, 22, 469-488. http://dx.doi.org/10.1016/j.idc.2008.03.010
|
[50]
|
Glatz, M., Fingerle, V., Wilske, B., Ambros-Rudolph, C., Kerl, H. and Müllegger, R.R. (2008) Immunoblot Analysis of the Seroreactivity to Recombinant Borrelia burgdorferi Sensu Lato Antigens, Including VlsE, in the Long-Term Course of Treated Patients with Erythema Migrans. Dermatology, 216, 93-103. http://dx.doi.org/10.1159/000111505
|
[51]
|
Kalish, R.A., McHugh, G., Granquist, J., et al. (2001) Persistence of Immunoglobulin M or Immunoglobulin G Antibody Responses to Borrelia burgdorferi 10 - 20 Years after Active Lyme Disease. Clinical Infectious Diseases, 33, 780-785. http://dx.doi.org/10.1086/322669
|
[52]
|
Wormser, G.P., Dattwyler, R.J., et al. (2006) The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. The Infectious Diseases Society of America.
|
[53]
|
Ledue, T.B., Collins, M.F., Young, J. and Schriefer, M.E. (2008) Evaluation of the Recombinant VlsE-Based Liaison Chemiluminescence Immunoassay for Detection of Borrelia burgdorferi and Diagnosis of Lyme Disease. Clinical and Vaccine Immunology, 15, 1796- 1804. http://dx.doi.org/10.1128/CVI.00195-08
|
[54]
|
Fritz, C.L. and Kjemtrup, A.M. (2003) Lyme Borreliosis. Journal of the American Veterinary Medical Association, 223, 1261-1270. http://dx.doi.org/10.2460/javma.2003.223.1261
|
[55]
|
Zore, A., Ruzic-Sabljic, E., Maraspin, V., et al. (2002) Sensitivity of Culture and Polymerase Chain Reaction for the Etiologic Diagnosis of Erythema Migrans. Wiener Klinische Wochenschrift, 114, 606-609.
|
[56]
|
Lagal, V., Postic, D., Rubic-Sabljic, E. and Baranton, G. (2003) Genetic Diversity among Borrelia Strains Determined by Single-Strand Conformation Polymorphism Analysis of the ospC Gene and Its Association with Invasiveness. Journal of Clinical Microbiology, 41, 5059-5065. http://dx.doi.org/10.1128/JCM.41.11.5059-5065.2003
|
[57]
|
Miller, J.C., Ma, Y., Bian, J., et al. (2008) A Critical Role for Type I IFN in Arthritis Development Following Borrelia burgdorferi Infection of Mice. The Journal of Immunology, 181, 8492-8503. http://dx.doi.org/10.4049/jimmunol.181.12.8492
|
[58]
|
Ekerfelt, C., Andersson, M., Olausson, A., et al. (2007) Mercury Exposure as a Model for Deviation of Cytokine Responses in Experimental Lyme Arthritis: HgCl2 Treatment Decreases T Helper Cell Type 1-Like Responses and Arthritis Severity but Delays Eradication of Borrelia burgdorferi in C3H/HeN Mice. Clinical & Experimental Immunology, 150, 189- 197. http://dx.doi.org/10.1111/j.1365-2249.2007.03474.x
|
[59]
|
Acha, P.N. and Szyfres, B. (Pan American Health Organization [PAHO]) (2003) Zoonoses and Communicable Diseases Common to Man and Animals. Volume 1. Bacterioses and Mycoses. 3rd Edition, Scientific and Technical Publication No. 580. Lyme Disease, PAHO, Washington DC, 179-184.
|
[60]
|
Aberer, E. (2007) Lyme Borreliosis—An Update. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 5, 406-414. http://dx.doi.org/10.1111/j.1610-0387.2007.06285.x
|
[61]
|
Von Lackum, K., Babb, K., Riley, S.P., Wattier, R.L., Bykowski, T. and Stevenson, B. (2006) Functionality of Borrelia burgdorferi LuxS: The Lyme Disease Spirochete Produces and Responds to the Pheromone Autoinducer-2 and Lacks a Complete Activated-Methyl Cycle. International Journal of Medical Microbiology, 296, 92-102.
http://dx.doi.org/10.1016/j.ijmm.2005.12.011
|
[62]
|
Trevejo, R.T., Krause, P.J., Sikand, V.K., Schriefer, M.E., Ryan, R., Lepore, T., et al. (1999) Evaluation of Two-Test Serodiagnostic Method for Early Lyme Disease in Clinical Practice. The Journal of Infectious Diseases, 179, 931-938. http://dx.doi.org/10.1086/314663
|
[63]
|
Steere, A.C. (2006) Lyme Borreliosis in 2005, 30 Years after Initial Observations in Lyme Connecticut. Wiener Klinische Wochenschrift, 118, 625-633.
http://dx.doi.org/10.1007/s00508-006-0687-x
|
[64]
|
Ball, R., Shadomy, S.V., Meyer, A., et al. (2009) HLA Type and Immune Response to Borrelia burgdorferi Outer Surface Protein A in People in Whom Arthritis Developed after Lyme Disease Vaccination. Arthritis & Rheumatology, 60, 1179-1186.
http://dx.doi.org/10.1002/art.24418
|
[65]
|
Masters, E.J., Grigery, C.N. and Masters, R.W. (2008) STARI, or Masters Disease: Lone Star tick-Vectored Lyme-Like Illness. Infectious Disease Clinics of North America, 22, 361-376.
http://dx.doi.org/10.1016/j.idc.2007.12.010
|
[66]
|
Schoen, R.T., Aversa, J.M., Rahn, D.W. and Steere, A.C. (1991) Treatment of Refractory Chronic Lyme Arthritis with Arthroscopic Synovectomy. Arthritis & Rheumatology, 34, 1056-1060. http://dx.doi.org/10.1002/art.1780340817
|
[67]
|
Kaplan, R.F. and Steere, A.C. (1999) Successful Treatment of Lyme Encephalopathy with iv. Ceftriaxone. The Journal of Infectious Diseases, 180, 377-383.
|
[68]
|
Pavia, C.S. (2003) Current and Novel Therapies for Lyme Disease. Expert Opinion on Investigational Drugs, 12, 1003-1016. http://dx.doi.org/10.1517/13543784.12.6.1003
|
[69]
|
Feder Jr., H.M., Johnson, B.J., O’Connell, S., et al. (2007) A Critical Appraisal of “Chronic Lyme Disease”. The New England Journal of Medicine, 357, 1422-1430.
|
[70]
|
Marques, A. (2008) Chronic Lyme Disease: A Review. Infectious Disease Clinics of North America, 22, 341-360. http://dx.doi.org/10.1016/j.idc.2007.12.011
|
[71]
|
McHugh.LA McHugh (2008) Effect of Electronic Laboratory Reporting on the Burden of Lyme Disease Surveillance—New Jersey, 2001-2006. Morbidity and Mortality Weekly Report, 57, 42-45.
|
[72]
|
Marques, A., Brown, M.R. and Fleisher, T.A. (2009) Natural Killer Cell Counts Are Not Different between Patients with Post-Lyme Disease Syndrome and Controls. Clinical and Vaccine Immunology, 16, 1249-1250. http://dx.doi.org/10.1128/CVI.00167-09
|
[73]
|
Ones, K.L., McHugh, G.A., Glickstein, L.J. and Steere, A.C. (2009) Analysis of Borrelia burgdorferi Genotypes in Patients with Lyme Arthritis: High Frequency of Ribosomal RNA Intergenic Spacer Type 1 Strains in Antibiotic-Refractory Arthritis. Arthritis & Rheumatology, 60, 2174-2182. http://dx.doi.org/10.1002/art.24812
|
[74]
|
Codolo, G., Amedei, A., Steere, A.C., et al. (2008) Borrelia burgdorferi NapA-Driven Th17 Cell Inflammation in Lyme Arthritis. Arthritis & Rheumatology, 58, 3609-3617.
http://dx.doi.org/10.1002/art.23972
|
[75]
|
Iliopoulou, B.P., Alroy, J. and Huber, B.T. (2007) CD28 Deficiency Exacerbates Joint Inflammation upon Borrelia burgdorferi Infection, Resulting in the Development of Chronic Lyme Arthritis. The Journal of Immunology, 179, 8076-8082.
http://dx.doi.org/10.4049/jimmunol.179.12.8076
|